Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Kohlmann

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
Haematologica|December 7, 2005
Detailed analysis of FLT3 expression levels in acute myeloid leukemiaFlorian Kuchenbauer, Wolfgang Kern, Claudia Schoch, et al.
Genes, Chromosomes & Cancer|March 8, 2005
AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypesTorsten Haferlach, Alexander Kohlmann, Susanne Schnittger, et al.
BMC Bioinformatics|December 17, 2009
Quantitative comparison of microarray experiments with published leukemia related gene expression signaturesHans-Ulrich Klein, Christian Ruckert, Alexander Kohlmann, et al.
Bioinformatics (Oxford, England)|February 26, 2011
R453Plus1Toolbox: an R/Bioconductor package for analyzing Roche 454 Sequencing dataHans-Ulrich Klein, Christoph Bartenhagen, Alexander Kohlmann, et al.
Haematologica|February 6, 2014
Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated casesAnnette Fasan, Claudia Haferlach, Alexander Kohlmann, et al.
British Journal of Haematology|June 14, 2014
A robust molecular pattern for myelodysplastic syndromes in two independent cohorts investigated by next-generation sequencing can be revealed by comparative bioinformatic analysesDominic Rose, Alexander Kohlmann, Yasunobu Nagata, et al.
Blood Reviews|May 6, 2018
Current status and trends in the diagnostics of AML and MDSEvgenii Shumilov, Johanna Flach, Alexander Kohlmann, et al.
Haematologica|March 23, 2011
CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemiaClaudia Haferlach, Ulrike Bacher, Alexander Kohlmann, et al.
Genes, Chromosomes & Cancer|December 21, 2004
Pattern robustness of diagnostic gene expression signatures in leukemiaAlexander Kohlmann, Claudia Schoch, Martin Dugas, et al.
Blood|May 16, 2014
TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosisAnna Stengel, Susanne Schnittger, Sandra Weissmann, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
Haematologica|December 7, 2005
Detailed analysis of FLT3 expression levels in acute myeloid leukemiaFlorian Kuchenbauer, Wolfgang Kern, Claudia Schoch, et al.
Genes, Chromosomes & Cancer|March 8, 2005
AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypesTorsten Haferlach, Alexander Kohlmann, Susanne Schnittger, et al.
BMC Bioinformatics|December 17, 2009
Quantitative comparison of microarray experiments with published leukemia related gene expression signaturesHans-Ulrich Klein, Christian Ruckert, Alexander Kohlmann, et al.
Bioinformatics (Oxford, England)|February 26, 2011
R453Plus1Toolbox: an R/Bioconductor package for analyzing Roche 454 Sequencing dataHans-Ulrich Klein, Christoph Bartenhagen, Alexander Kohlmann, et al.
Haematologica|February 6, 2014
Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated casesAnnette Fasan, Claudia Haferlach, Alexander Kohlmann, et al.
British Journal of Haematology|June 14, 2014
A robust molecular pattern for myelodysplastic syndromes in two independent cohorts investigated by next-generation sequencing can be revealed by comparative bioinformatic analysesDominic Rose, Alexander Kohlmann, Yasunobu Nagata, et al.
Blood Reviews|May 6, 2018
Current status and trends in the diagnostics of AML and MDSEvgenii Shumilov, Johanna Flach, Alexander Kohlmann, et al.
Haematologica|March 23, 2011
CDKN1B, encoding the cyclin-dependent kinase inhibitor 1B (p27), is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemiaClaudia Haferlach, Ulrike Bacher, Alexander Kohlmann, et al.
Genes, Chromosomes & Cancer|December 21, 2004
Pattern robustness of diagnostic gene expression signatures in leukemiaAlexander Kohlmann, Claudia Schoch, Martin Dugas, et al.
Blood|May 16, 2014
TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosisAnna Stengel, Susanne Schnittger, Sandra Weissmann, et al.
Pageof 11